A possible role of cyclooxygenase‐2 in the relationship between sleep and sudden unexpected death in epilepsy

@article{Matos2012APR,
  title={A possible role of cyclooxygenase‐2 in the relationship between sleep and sudden unexpected death in epilepsy},
  author={Gabriela Matos and Laura Bennedsen and Vanessa Atha{\'i}de Garcia and F{\'u}lvio Alexandre Scorza and Esper Abr{\~a}o Cavalheiro and S{\'e}rgio Tufik and Monica Levy Andersen},
  journal={Epilepsia},
  year={2012},
  volume={53}
}
To the Editors: We have read the recent article by Chuang et al. (2012) with great interest. They studied the effects of long-term antiepileptic drug (AED) monotherapy on vascular risk factors and atherosclerosis. They proved that treatment with carbamazepine (CBZ), phenytoin, or valproic acid (VPA) is significantly associated with acceleration of atherosclerosis in patients with epilepsy. Their findings were significantly associated with the duration of AED treatment. Authors concluded that… 

References

SHOWING 1-10 OF 24 REFERENCES

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.

Elevation of ADMA is associated with impaired endothelium-dependent vasodilation and reduced urinary nitrate excretion and this abnormality is reversed by administration of L-arginine.

Sleep, epilepsy and translational research: What can we learn from the laboratory bench?

Effects of long‐term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis

Purpose:  Long‐term therapy with antiepileptic drugs (AEDs) has been associated with metabolic consequences that lead to an increase in risk of atherosclerosis in patients with epilepsy. We compared

Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury: Framingham Offspring Study

Higher plasma ADMA values were associated with an increased prevalence of SBIs, after adjustment for traditional stroke risk factors, suggesting ADMA may be a potentially useful new biomarker of subclinical vascular brain injury, which is an important correlate of vascular cognitive impairment and risk of stroke.

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

Ablation of Cyclooxygenase-2 in Forebrain Neurons is Neuroprotective and Dampens Brain Inflammation after Status Epilepticus

Results following pilocarpine-induced status epilepticus indicate that seizure-induced neuronal COX-2 expression in neurons promotes early neuroprotection and then delayed neurodegeneration of CA1 pyramidal neurons, and is essential for development of a leaky blood–brain barrier after seizures.

Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2

A suite of small molecules with a 3-aryl-acrylamide scaffold as selective EP2 antagonists raise the possibility that selective block of EP2 signaling via small molecules can be an innovative therapeutic strategy for inflammation-related brain injury.

Effects of COX-2 Inhibitor in Temporomandibular Joint Acute Inflammation

Etoricoxib improved the sleep parameters, suggesting the involvement of the cyclo-oxygenase-2 enzyme in acute inflammation of the TMJ, specifically in REM sleep.

The relationship between sleep and epilepsy: Evidence from clinical trials and animal models